These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 9792384

  • 1. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection.
    Giorgi JV, Majchrowicz MA, Johnson TD, Hultin P, Matud J, Detels R.
    AIDS; 1998 Oct 01; 12(14):1833-44. PubMed ID: 9792384
    [Abstract] [Full Text] [Related]

  • 2. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM, Schapiro JM, Winters MA, Merigan TC.
    AIDS Res Hum Retroviruses; 1998 May 01; 14(7):561-9. PubMed ID: 9591710
    [Abstract] [Full Text] [Related]

  • 3. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M, García F, Gallart T, Tortajada C, Soriano A, Palou E, Maleno MJ, Barceló JJ, Vidal C, Cruceta A, Miró JM, Gatell JM.
    AIDS; 2000 Sep 08; 14(13):1921-33. PubMed ID: 10997396
    [Abstract] [Full Text] [Related]

  • 4. Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.
    Plana M, Martínez C, García F, Maleno MJ, Barceló JJ, García A, Lejeune M, Vidal C, Cruceta A, Miró JM, Pumarola T, Gallart T, Gatell JM.
    J Acquir Immune Defic Syndr; 2002 Apr 15; 29(5):429-34. PubMed ID: 11981357
    [Abstract] [Full Text] [Related]

  • 5. Differences in cellular activation and apoptosis in HIV-infected patients receiving protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    Benito JM, López M, Martín JC, Lozano S, Martínez P, González-Lahoz J, Soriano V.
    AIDS Res Hum Retroviruses; 2002 Dec 10; 18(18):1379-88. PubMed ID: 12487809
    [Abstract] [Full Text] [Related]

  • 6. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.
    Lederman MM, Connick E, Landay A, Kuritzkes DR, Spritzler J, St Clair M, Kotzin BL, Fox L, Chiozzi MH, Leonard JM, Rousseau F, Wade M, Roe JD, Martinez A, Kessler H.
    J Infect Dis; 1998 Jul 10; 178(1):70-9. PubMed ID: 9652425
    [Abstract] [Full Text] [Related]

  • 7. Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease.
    Samri A, Goodall R, Burton C, Imami N, Pantaleo G, Kelleher A, Poli G, Gotch F, Autran B.
    Antivir Ther; 2007 Jul 10; 12(4):553-8. PubMed ID: 17668564
    [Abstract] [Full Text] [Related]

  • 8. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4+ T cell population with memory rather than naive cells.
    Evans TG, Bonnez W, Soucier HR, Fitzgerald T, Gibbons DC, Reichman RC.
    Antiviral Res; 1998 Oct 10; 39(3):163-73. PubMed ID: 9833957
    [Abstract] [Full Text] [Related]

  • 9. Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen.
    Landay AL, Spritzler J, Kessler H, Mildvan D, Pu M, Fox L, O'Neil D, Schock B, Kuritzkes D, Lederman MM, AIDS Clinical Trials Group 5014 Team.
    J Infect Dis; 2003 Nov 15; 188(10):1444-54. PubMed ID: 14624369
    [Abstract] [Full Text] [Related]

  • 10. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR, Zaunders JJ, Cunningham P, Cooper DA.
    AIDS Res Hum Retroviruses; 1999 Jul 20; 15(11):963-72. PubMed ID: 10445808
    [Abstract] [Full Text] [Related]

  • 11. Evidence of immune reconstitution in antiretroviral drug-experienced patients with advanced HIV disease.
    Landay AL, Bettendorf D, Chan E, Spritzler J, Schmitz JL, Bucy RP, Gonzalez CJ, Schnizlein-Bick CT, Evans T, Squires KE, Phair JP.
    AIDS Res Hum Retroviruses; 2002 Jan 20; 18(2):95-102. PubMed ID: 11839142
    [Abstract] [Full Text] [Related]

  • 12. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
    Zaunders JJ, Cunningham PH, Kelleher AD, Kaufmann GR, Jaramillo AB, Wright R, Smith D, Grey P, Vizzard J, Carr A, Cooper DA.
    J Infect Dis; 1999 Aug 20; 180(2):320-9. PubMed ID: 10395845
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical experience with adding delavirdine to combination therapy in patients in whom multiple antiretroviral treatment including protease inhibitors has failed.
    Bellman PC.
    AIDS; 1998 Jul 30; 12(11):1333-40. PubMed ID: 9708413
    [Abstract] [Full Text] [Related]

  • 15. Immune reconstitution after successful treatment with protease inhibitor-based and protease inhibitor-sparing antiretroviral regimens.
    Smith KY, Steffens CM, Truckenbrod A, Landay A, Al-Harthi L.
    J Acquir Immune Defic Syndr; 2002 Apr 15; 29(5):544-5. PubMed ID: 11981373
    [No Abstract] [Full Text] [Related]

  • 16. Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.
    Al-Harthi L, Siegel J, Spritzler J, Pottage J, Agnoli M, Landay A.
    AIDS; 2000 May 05; 14(7):761-70. PubMed ID: 10839583
    [Abstract] [Full Text] [Related]

  • 17. Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy.
    Staszewski S, Miller V, Sabin C, Schlecht C, Gute P, Stamm S, Leder T, Berger A, Weidemann E, Hill A, Phillips A.
    AIDS; 1999 May 28; 13(8):951-6. PubMed ID: 10371176
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease.
    Mezzaroma I, Carlesimo M, Pinter E, Alario C, Sacco G, Muratori DS, Bernardi ML, Paganelli R, Aiuti F.
    AIDS; 1999 Jul 09; 13(10):1187-93. PubMed ID: 10416521
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.